Bio-Rad Corp (BIO): Price to Sales

Symbol and logo of brand Bio-Rad Laboratories, Inc. (BIO)

Logistics and reagent optimization via outsourcing supports the stability of Bio-Rad Laboratories (BIO), and the overall price-to-sales dynamics on GURU.Markets reflect this trend, where the value of 3.10 reflects this status. Growth is driven by developments in digital PCR and AI platforms, while the company adheres to moderate environmental standards in waste management.

bio-rad.com (BIO) Price-to-Revenue Ratio: for the period 07/04/2022 - 11/13/2026

Analytical breakdowns for Bio-Rad Laboratories Inc (BIO)

- price and consensus price forecast:
Market Chart bio-rad.com|BIO - Price Target Chart
- stock exchange capitalization data:
Market Value Bio-Rad Corp|BIO - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value of One Share Bio-Rad|BIO - Company Book Value|Market Value to Book Value bio-rad.com|BIO - Company Total Assets
- business debt structure and liquidity details:
Total Debt to Capital Bio-Rad Laboratories|BIO - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio Bio-Rad Corp|BIO - Company Total Debt|Debt to Net Assets Ratio Bio-Rad Corp|BIO - Company Long-Term Debt|Company Short-Term Debt Bio-Rad|Quick Ratio bio-rad.com
- earnings and market multiples details:
BIO - Net Profit|Expected Profit Bio-Rad Laboratories|BIO - Price to Earnings Ratio|Projected Price to Earnings Ratio Bio-Rad Laboratories, Inc.|BIO - Price/Earnings to Growth Ratio|Business Value to Operating Income Before Depreciation Bio-Rad Corp|BIO - Operating profit EBITDA|Net earnings per share (EPS TTM) Bio-Rad|BIO - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months bio-rad.com|BIO - Earnings per share growth in current year|Expected net earnings per share growth next year Bio-Rad Laboratories
- total revenue and sales volume data:
BIO - Company Revenue|Company Future Revenue bio-rad.com|BIO - P/S Multiple|Market Cap to Expected Sales Ratio Bio-Rad Corp
Summary company analytics:bio-rad.com, BIO
Signature product of bio-rad.com

The P/S multiple determines the market value of one dollar of revenue, allowing for an assessment of business scaling efficiency regardless of current profitability. By analyzing the P/S multiple chart, an investor can see the ratio of market capitalization to turnover, which is critical for Bio-Rad Laboratories (BIO), where stable demand for consumables and test systems smooths valuation volatility amid a temporary decline in core equipment sales.

Competitors of Bio-Rad Laboratories

Price-to-Revenue Coefficient agilent.com|Price-to-Revenue Ratio Quest Diagnostics Incorporated DGX|Illumina Inc (ILMN) - Price to Sales|EXAS: Market Cap to Revenue|Price-to-Revenue Multiple Revvity Corp (RVTY)|Anbio Biotechnology (NNNN) - Price-to-Revenue Ratio|soterahealth.com - Market Capitalization-to-Revenue Ratio|QDEL (QuidelOrtho Corporation) - P/S Multiple|P/S Multiple OPKO Health Inc|P/S Multiple CDNA|Maravai - Market Cap to Revenue Ratio|Fulgent Genetics, Inc. - Market Cap to Revenue|Market Capitalization-to-Revenue Ratio LAB|CTKB - Price-to-Revenue Ratio|OSUR: Price-to-Revenue Ratio|XGN: P/S Multiple|MDxHealth, Inc. (MDXH) - P/S Multiple|LUCD (Lucid Diagnostics Inc.) - P/S Multiple|Price-to-Revenue Ratio PRE|Price-to-Revenue Ratio Insight Molecular Diagnostics (IMDX)|TRIB - Price to Sales|Price-to-Revenue Ratio ProPhase PRPH|Market Capitalization-to-Revenue Ratio AIMD|Co-Diagnostics, Inc. - P/S Multiple|HSCS - P/S Multiple|BMRA (Biomerica) - Market Cap to Revenue|CDIO: Market Cap to Sales Volume|Price-to-Revenue Ratio Onconetix Corp|Price to Sales Virax Biolabs Corp VRAX|Price-to-Revenue Ratio Bluejay Diagnostics (BJDX)|AWH (aspirawh.com) - Market Capitalization-to-Revenue Ratio|P/S Multiple AXDX (Accelerate Diagnostics, Inc.)|Price-to-Revenue Coefficient Centogene N.V. (CNTG)|Enzo - P/S Multiple|Price to Sales Fresh2 Group Limited|gtglabs.com (GENE) - Price-to-Revenue Ratio|ME - Price-to-Revenue Coefficient|PMD (Psychemedics Corporation) - P/S Multiple